retatrutide regulatory approval Availability & Timeline Retatrutide: FDA approval time, trial

(2021) and Delpino et al

Retatrutide produced concentration-dependent increases in contractile force starting at 10 nanomolar concentrations and reaching plateau at 100 nanomolar

Anti-Aging Combats oxidative stress, supporting cellular repair and longevity

No funding was received to assist with the preparation of this manuscript

Therefore, further clinical studies are needed to verify whether therapies GLP-1 functional agonists could be used as supportive therapy to currently available antidepressant drugs or whether these compounds would have a beneficial effect in patients suffering from treatment-resistant depression [120]

2022;37(18):e146